Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-037202

Director sold 21,640 shares at an average $6.28 ($135,951)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bernard Gordon R Director 2019-05-28 Sale −3,789 $6.44 $24,401 114,940 D
Bernard Gordon R Director 2019-05-29 Sale −1,800 $6.38 $11,484 113,140 D
Bernard Gordon R Director 2019-05-30 Sale −663 $6.46 $4,283 112,477 D
Bernard Gordon R Director 2019-05-31 Sale −742 $6.46 $4,793 111,735 D
Bernard Gordon R Director 2019-06-03 Sale −1,120 $6.33 $7,090 110,615 D
Bernard Gordon R Director 2019-06-04 Sale −1,300 $6.46 $8,398 109,315 D
Bernard Gordon R Director 2019-06-05 Sale −2,500 $6.55 $16,375 106,815 D
Bernard Gordon R Director 2019-06-06 Sale −1,495 $6.22 $9,299 105,320 D
Bernard Gordon R Director 2019-06-07 Sale −2,278 $5.99 $13,645 103,042 D
Bernard Gordon R Director 2019-06-10 Sale −3,549 $6.03 $21,400 99,493 D
Bernard Gordon R Director 2019-06-11 Sale −942 $6.21 $5,850 98,551 D
Bernard Gordon R Director 2019-06-12 Sale −1,462 $6.11 $8,933 97,089 D
Open-market sales · 21,640 sh · avg $6.28 · $135,951
Loading xslF345X03/doc4.xml…